Key result
Inability to find an effective drug to eliminate atrial flutter was associated with a higher rate of cardiac death compared to treatment with an effective drug.
Why the study?
As children with cardiac disease grow older, atrial flutter becomes more prevalent, prompting an investigation into their clinical characteristics and factors affecting prognosis.
What are the clinical characteristics, treatment efficacy, and prognostic factors in young patients with atrial flutter?
Observational (n=380)
Yes
What are the clinical characteristics, treatment efficacy, and prognostic factors in young patients with atrial flutter?
In young patients with atrial flutter, predominantly those with congenital heart disease, effective pharmacological elimination of the arrhythmia is associated with significantly lower cardiac mortality.
Answers are grounded in this paper and cite their sources.
Effective AAD control was associated with lower mortality in young atrial flutter; leaves open causal benefit and need for randomized confirmation.
As children with cardiac disease grow older, atrial flutter becomes more prevalent. A collaborative study was performed in 19 institutions to determine the clinical characteristics of these children and the factors affecting prognosis. There were 380 patients with one or more electrocardiographically documented episodes of atrial flutter that first occurred between ages 1 and 25 years (mean age at onset 10.3). Episodes of flutter continued to occur for a mean of 2.5 years after the onset. Of the 380 patients, 60% had repaired congenital heart disease, 13% palliated congenital heart disease, 8% unoperated congenital heart disease, 8% an otherwise normal heart, 6% cardiomyopathy, 4% rheumatic heart disease and 2% other lesions. Overall, drugs were effective in eliminating atrial flutter in 58% of patients; specifically, amiodarone and digoxin plus quinidine were effective in 53%, digoxin alone in 44% and propranolol in 21%. Amiodarone was effective in seven (78%) of nine patients. Corrective surgery was performed after the onset of atrial flutter in 66 patients; in 52% the atrial flutter was easier to control or it resolved and in only 4% it was worse. At follow-up (mean 6.5 years), 83% of the patients were alive (49% without atrial flutter and 34% with atrial flutter) and 17% died (10% suddenly, 6% of nonsudden cardiac cause and 1% of noncardiac cause). Cardiac death occurred in 20% of those for whom an effective drug could not be found to eliminate atrial flutter compared with 5% of those who were treated with an effective drug (p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Garson et al. (1985) conducted an observational in Atrial flutter (n=380). Inability to find an effective drug for atrial flutter vs. Treatment with an effective drug was evaluated on Cardiac death (p=<0.001). Inability to find an effective drug to eliminate atrial flutter was associated with a higher rate of cardiac death compared to treatment with an effective drug.
Synapse has enriched 10 related papers. Consider them for comparative context: